Art

J-GLOBAL ID：202002216606990047   Reference number：20A1513727

A randomized phase II trial of cisplatin plus gemcitabine versus carboplatin plus gemcitabine in patients with completely resected non-small cell lung cancer: Hokkaido Lung Cancer Clinical Study Group Trial (HOT0703)

完全切除非小細胞肺癌患者におけるシスプラチン+ゲムシタビン対カルボプラチン+ゲムシタビンの無作為化第II相試験:北海道肺癌臨床試験グループ試験(HOT0703)【JST・京大機械翻訳】

Author (19)： Fukumoto Shin-ichi (Department of Respiratory Medicine, National Hospital Organization Hokkaido Cancer Center, Sapporo, Japan) ,  Oizumi Satoshi (First Department of Medicine, Hokkaido University Hospital, Sapporo, Japan) ,  Harada Masao (Department of Respiratory Medicine, National Hospital Organization Hokkaido Cancer Center, Sapporo, Japan) ,  Sukoh Noriaki (Department of Respiratory Medicine, National Hospital Organization Hokkaido Cancer Center, Sapporo, Japan) ,  Nakano Kosuke (Department of Respiratory Medicine, National Hospital Organization Hokkaido Cancer Center, Sapporo, Japan) ,  Fuke Satoshi (Department of Medical Oncology, KKR Sapporo Medical Center, Sapporo, Japan) ,  Sakakibara-Konishi Jun (First Department of Medicine, Hokkaido University Hospital, Sapporo, Japan) ,  Takamura Kei (Department of Respiratory Medicine, Obihiro-Kosei General Hospital, Obihiro, Japan) ,  Ito Kenichiro (Department of Respiratory Medicine, Obihiro-Kosei General Hospital, Obihiro, Japan) ,  Fujita Yuka (Department of Respiratory Medicine, National Hospital Organization Asahikawa Medical Center, Asahikawa, Japan) ,  Nishigaki Yutaka (Department of Respiratory Medicine, National Hospital Organization Asahikawa Medical Center, Asahikawa, Japan) ,  Harada Toshiyuki (Center for Respiratory Diseases, JCHO Hokkaido Hospital, Sapporo, Japan) ,  Akie Kenji (Department of Respiratory Medicine, Sapporo City General Hospital, Sapporo, Japan) ,  Kinoshita Ichiro (Department of Medical Oncology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo, Japan) ,  Amano Toraji (Department of Medical Oncology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo, Japan) ,  Isobe Hiroshi (Department of Medical Oncology, KKR Sapporo Medical Center, Sapporo, Japan) ,  Dosaka-Akita Hirotoshi (Department of Medical Oncology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo, Japan) ,  Nishimura Masaharu (First Department of Medicine, Hokkaido University Hospital, Sapporo, Japan) ,  the Hokkaido Lung Cancer Clinical Study Group
Material： Cancer Chemotherapy and Pharmacology
Volume： 86  Issue： 1  Page： 117-127  Publication year： 2020 
JST Material Number： W4134A  ISSN： 1432-0843  Document type： Article
Article type： 原著論文  Country of issue： Germany, Federal Republic of (DEU)  Language： ENGLISH (EN)

Abstract/Point： Abstract: Purpose: This study...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=20A1513727&from=J-GLOBAL&jstjournalNo=W4134A") }}

Thesaurus term： 4 stroke cycle ,  *lung tumor ,  Adenocarcinoma ,  *non-small cell lung cancer ,  excision repair ,  *phase 2 study ,  biomarker ,  tolerability ,  end point ,  *platinum complex ,  *antitumor drug ,  *ammine complex ,  *chloro complex ,  halogeno sugar ,  deoxyribonucleoside
Semi thesaurus term： *cisplatin ,  *carboplatin ,  補助化学療法 ,  *完全切除 ,  全生存率 , 【Automatic Indexing@JST】

Author keywords (4)： Adjuvant chemotherapy ,  Gemcitabine ,  Non-small cell lung cancer ,  Platinum

JST classification (2)： Drug therapy(=pharmacotherapy)for tumors  (GE03032C) ,  Clinical application of antitumor(=antineoplastic)drugs  (GW16020L)

Substance index (1)： Gemcitabine

Terms in the title (11)： 完全切除 ,  非小細胞肺癌 ,  患者 ,  シスプラチン ,  ゲムシタビン ,  カルボプラチン ,  第II相試験 ,  北海道 ,  肺癌 ,  臨床試験 ,  グループ試験